AAAAAA
Results: 1-25/28
Authors:
Fischbach, PS
Barrett, TD
Goyal, R
Tran, BC
Syed, ZA
Hennan, JK
Lucchesi, BR
Citation: Ps. Fischbach et al., Conversion of atrial fibrillation by the experimental antiarrhythmic drug tedisamil in two canine models, J CARD ELEC, 12(10), 2001, pp. 1138-1144
Authors:
Hasan, AAK
Schmaier, AH
Warnock, MA
Normolle, D
Driscoll, E
Lucchesi, BR
Werns, SW
Citation: Aak. Hasan et al., Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries, THROMB HAEM, 86(5), 2001, pp. 1296-1304
Authors:
Patel, MB
Kilgore, KS
Ortolano, GA
Gryboski, CL
Qureshi, MA
Marcovitz, P
Naylor, KB
Park, JL
Wenz, B
Gikakis, N
Freedman, RJ
Lucchesi, BR
O'Neill, WW
Citation: Mb. Patel et al., Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction, PERFUSION-U, 16, 2001, pp. 39-49
Authors:
Huang, JB
Feldbaum, VM
Lucchesi, BR
Werns, SW
Citation: Jb. Huang et al., Effects of adenosine on thrombosis and thrombolysis in a canine experimental preparation, PHARMACOL, 63(3), 2001, pp. 166-174
Authors:
Hennan, JK
Huang, JB
Barrett, TD
Driscoll, EM
Willens, DE
Park, AM
Crofford, LJ
Lucchesi, BR
Citation: Jk. Hennan et al., Effects of selective cyclooxygenase-2 inhibition on vascular responses andthrombosis in canine coronary arteries, CIRCULATION, 104(7), 2001, pp. 820-825
Authors:
Barrett, TD
Hennan, JK
Fischbach, PS
O'Neill, BP
Driscoll, EM
Lucchesi, BR
Citation: Td. Barrett et al., Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence, BR J PHARM, 132(7), 2001, pp. 1493-1500
Authors:
Tanhehco, EJ
Lucchesi, BR
Citation: Ej. Tanhehco et Br. Lucchesi, Therapeutic potential of complement inhibitors in myocardial ischaemia, EXPERT OP I, 9(5), 2000, pp. 975-991
Authors:
Rebello, SS
Huang, J
Faul, JD
Lucchesi, BR
Citation: Ss. Rebello et al., Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists, J THROMB TH, 9(1), 2000, pp. 23-28
Authors:
Tanhehco, EJ
Yasojima, K
McGeer, PL
McGeer, EG
Lucchesi, BR
Citation: Ej. Tanhehco et al., Preconditioning reduces myocardial complement gene expression in vivo, AM J P-HEAR, 279(3), 2000, pp. H1157-H1165
Authors:
Tanhehco, EJ
Yasojima, K
McGeer, PL
Washington, RA
Lucchesi, BR
Citation: Ej. Tanhehco et al., Free radicals upregulate complement expression in rabbit isolated heart, AM J P-HEAR, 279(1), 2000, pp. H195-H201
Authors:
Tanhehco, EJ
Lee, HY
Lucchesi, BR
Citation: Ej. Tanhehco et al., Sublytic complement attack reduces infarct size in rabbit isolated hearts:evidence for C5a-mediated cardioprotection, IMMUNOPHARM, 49(3), 2000, pp. 391-399
Authors:
Rebello, SS
Blank, HS
Lucchesi, BR
Citation: Ss. Rebello et al., Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis, THROMB RES, 98(6), 2000, pp. 531-540
Authors:
Huang, JB
Driscoll, EM
Gonzales, ML
Park, AM
Lucchesi, BR
Citation: Jb. Huang et al., Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model, J PHARM EXP, 295(2), 2000, pp. 492-499
Authors:
Tanhehco, EJ
Yasojima, K
McGeer, PL
Lucchesi, BR
Citation: Ej. Tanhehco et al., Acute cocaine exposure up-regulates complement expression in rabbit heart, J PHARM EXP, 292(1), 2000, pp. 201-208
Authors:
Kilgore, KS
Lucchesi, BR
Citation: Ks. Kilgore et Br. Lucchesi, Neutrophils and altered myocardial function, AM HEART J, 139(1), 2000, pp. 32-34
Authors:
Tanhehco, EJ
Yasojima, K
McGeer, PL
Washington, RA
Kilgore, KS
Homeister, JW
Lucchesi, BR
Citation: Ej. Tanhehco et al., Preconditioning reduces tissue complement gene expression in the rabbit isolated heart, AM J P-HEAR, 277(6), 1999, pp. H2373-H2380
Authors:
Hasan, AAK
Rebello, SS
Smith, E
Srikanth, S
Werns, S
Driscoll, E
Faul, J
Brenner, D
Normolle, D
Lucchesi, BR
Schmaier, AH
Citation: Aak. Hasan et al., Thrombostatin inhibits induced canine coronary thrombosis, THROMB HAEM, 82(3), 1999, pp. 1182-1187
Authors:
Fischbach, PS
Johnston, PV
Friedrichs, GS
Lucchesi, BR
Citation: Ps. Fischbach et al., Tedisamil in a chronic canine model of atrial flutter, J CARDIO PH, 34(2), 1999, pp. 212-218
Authors:
Tanhehco, EJ
Kilgore, KS
Naylor, KB
Park, JL
Booth, EA
Lucchesi, BR
Citation: Ej. Tanhehco et al., Reduction of myocardial infarct size after ischemia and reperfusion by theglycosaminoglycan pentosan polysulfate, J CARDIO PH, 34(1), 1999, pp. 153-161
Authors:
Chi, L
Rebello, S
Lucchesi, BR
Citation: L. Chi et al., In vivo models of thrombosis, HANDB EXP P, 132, 1999, pp. 101-127
Authors:
Tanhehco, EJ
Kilgore, KS
Liff, DA
Murphy, KL
Fung, MS
Sun, WN
Sun, C
Lucchesi, BR
Citation: Ej. Tanhehco et al., The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system, TRANSPLAN P, 31(5), 1999, pp. 2168-2171
Authors:
Huang, JB
Rebello, SS
Faul, JD
Lucchesi, BR
Citation: Jb. Huang et al., Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition, PHARMACOL, 58(5), 1999, pp. 252-264
Authors:
Park, JL
Kilgore, KS
Naylor, KB
Booth, EA
Murphy, KL
Lucchesi, BR
Citation: Jl. Park et al., N-acetylheparin pretreatment reduces infarct size in the rabbit, PHARMACOL, 58(3), 1999, pp. 120-131
Authors:
Schwartz, CF
Kilgore, KS
Homeister, JW
Levy, BA
Lucchesi, BR
Bolling, SF
Citation: Cf. Schwartz et al., Increased rat cardiac allograft survival by the glycosaminoglycan pentosanpolysulfate, J SURG RES, 86(1), 1999, pp. 24-28
Authors:
Kilgore, KS
Tanhehgo, EJ
Naylor, KB
Lucchesi, BR
Citation: Ks. Kilgore et al., Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion, J PHARM EXP, 290(3), 1999, pp. 1041-1047